Female Physicians Face Higher Rates of Infertility and Pregnancy Complications
As female physicians tend to delay pregnancy until after their residencies, they are more susceptible to fertility issues. Nearly one in four female physicians...
After a Pandemic-Driven Boom, Telehealth Visits Level Off
According to recent data, telehealth visits are leveling off from their pandemic highs to below 20% of total medical appointments.
Overall telehealth use for doctor’s...
Democratic Senators Oppose Drug Pricing Proposal
Senators Scott Peters (D-CA), Kathleen Rice (D-NY), and Kurt Shrader (D-OR) have announced they will oppose Democrats’ drug pricing proposal, citing concerns about a...
Voxelotor Granted Priority Review for Children With Sickle Cell Disease
The U.S. Food and Drug Administration (FDA) has accepted Global Blood Therapeutics’ (GBT’s) supplemental New Drug Application (sNDA) seeking accelerated approval for voxelotor for...
Could Changing Indoor Air Quality Standards Eliminate Respiratory Illnesses?
Sewage systems in London vanquished cholera in the 19th century. Pesticides, wide-scale landscape management, and window screens that kept out mosquitos eliminated yellow fever...
Cognitive Decline Observed Six Months After Chemotherapy in Patients With Lymphoma
Patients with lymphoma tend to report and show signs of worsening cognitive function at six months after chemotherapy compared with healthy controls, according to...
Asciminib Superior to Bosutinib in Chronic-Phase CML
Asciminib was more effective than bosutinib at improving the rate of a major molecular response in patients with chronic myeloid leukemia in chronic phase...
Zanubrutinib Approved for Waldenström Macroglobulinemia
The U.S. Food and Drug Administration (FDA) has approved zanubrutinib for the treatment of adult patients with Waldenström macroglobulinemia (WM).
This approval is based on...
Two Decades After 9/11, Cancer and Other Chronic Conditions Linger
The World Trade Center Health Program (WTCHP) has identified around 70 forms of cancer stemming from the September 11, 2001 terrorist attack, affecting first...
FDA Grants Orphan Drug Designation to Gavo-Cel for Cholangiocarcinoma
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to T-cell therapy gavocabtagene autoleucel (gavo-cel) for the treatment of cholangiocarcinoma.
TCR2 Therapeutics, the...
Current Issue
September 2021 Volume 7 Issue 11
This issue discusses fertility preservation for young patients with cancer, reviews treatment options for primary immune thrombocytopenia, and more.